Reumatizam, Vol. 57 No. 2, 2010.
Meeting abstract
Golimumab (Simponi®) - first subcutaneous anti-TNF with once-monthly application
Đurđica Babić-Naglić
; Clinic for Rheumatic Diseases and Rehabilitation, Clinical Hospital Centre Zagreb, Zagreb, Croatia
Branimir Anić
; Department for Clinical Immunology and Rheumatology, Clinic for Internal Medicine, Clinical Hospital Centre Zagreb, Zagreb, Croatia
Srđan Novak
; Department for Rheumatology and Clinical Immunology, Clinic for Internal Medicine, Clinical Hospital Centre Rijeka, Rijeka, Croatia
Abstract
Keywords
Hrčak ID:
124667
URI
Publication date:
14.10.2010.
Visits: 1.158 *